Chris A. Rallis is Director at FENNEC PHARMACEUTICALS INC. (FENC). They have made 4 open-market trades across 1 company since 2022, most recently 2026-05-11.
CIK 0001185945
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FENC | SELL · 10b5-1 | 2026-05-11 | 2026-05-12 | $7.04 | $59K | +42.1% | +26.7% | +56.3% |
| FENC | SELL · 10b5-1 | 2025-10-10 | 2025-10-14 | $9.24 | $16K | +7.8% | -7.8% | -8.6% |
| FENC | SELL · 10b5-1 | 2025-07-07 | 2025-07-07 | $8.71 | $10K | +2.1% | -4.8% | +13.7% |
| FENC | SELL · 10b5-1 | 2025-04-11 | 2025-04-11 | $4.95 | $7K | +11.6% | +22.9% | +77.3% |
| FENC | SELL · 10b5-1 | 2025-02-14 | 2025-02-14 | $6.82 | $8K | +2.7% | -5.5% | -2.1% |
| FENC | SELL · 10b5-1 | 2024-12-02 | 2024-12-02 | $6.14 | $39K | -0.3% | +2.6% | +10.4% |
| FENC | SELL · 10b5-1 | 2024-10-08 | 2024-10-10 | $4.53 | $6K | +8.9% | +2.2% | +45.8% |
| FENC | SELL · 10b5-1 | 2024-07-05 | 2024-07-08 | $6.03 | $7K | +8.7% | -1.2% | -21.6% |
| FENC | SELL · 10b5-1 | 2024-04-15 | 2024-04-15 | $10.45 | $8K | -10.3% | -31.6% | -35.9% |
| FENC | SELL · 10b5-1 | 2024-03-26 | 2024-03-27 | $10.97 | $23K | -2.8% | -17.8% | -44.6% |
| FENC | SELL | 2023-12-26 | 2023-12-28 | $10.90 | $15K | -10.8% | -14.6% | -3.9% |
| FENC | SELL · 10b5-1 | 2023-11-20 | 2023-11-20 | $8.25 | $2K | +3.0% | +23.6% | +5.0% |
| FENC | SELL | 2023-08-18 | 2023-08-18 | $7.85 | $5K | +4.8% | -6.5% | +2.5% |
| FENC | SELL | 2023-07-24 | 2023-07-24 | $8.17 | $111K | -1.2% | -2.2% | -16.2% |
| FENC | SELL | 2023-07-06 | 2023-07-06 | $8.47 | $19K | +2.7% | -6.0% | -24.9% |
| FENC | SELL · 10b5-1 | 2023-05-19 | 2023-05-19 | $7.36 | $13K | +7.9% | +28.0% | +5.9% |
| FENC | SELL · 10b5-1 | 2022-11-17 | 2022-11-17 | $7.99 | $3K | +17.9% | +20.0% | +14.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.